Latest News

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g





BALTIMORE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Ceftriaxone?src=hash" target="_blank"gt;#Ceftriaxonelt;/agt;–Lupin Pharmaceuticals, Inc. is voluntarily recalling Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g to the hospital/physician level.

Source link





Related posts

Surprisingly, Coronavirus Pandemic Offers These Opportunities To Improve Mental Health

Newsemia

Heavily Processed Foods Cause Overeating And Weight Gain

Newsemia

Easing Sleep Apnea May Be Key to Stroke Recovery

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy